• Explore /
  • Poster
  • / HER3 as a biomarker of prognosis and panitumumab (Pan) benefit in <i>RAS</i>-wt advanced colorectal cancer (aCRC).

HER3 as a biomarker of prognosis and panitumumab (Pan) benefit in RAS-wt advanced colorectal cancer (aCRC).

Abstract Poster

Authors

null

Jenny F. Seligmann

University of Leeds, Leeds, United Kingdom

Jenny F. Seligmann , Faye Elliott , Bart Jacobs , Ace Joseph Hatch , Alexander Sibley , Susan Richman , Chen Jiang , Jenny Barrett , Kouros Owzar , Philip Quirke , Herbert Hurwitz , Matthew T. Seymour , Andrew B. Nixon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3583)

DOI

10.1200/jco.2015.33.15_suppl.3583

Abstract #

3583

Poster Bd #

76

Abstract Disclosures

Similar Posters

First Author: Jenny F. Seligmann

First Author: Pierre Laurent-Puig

First Author: Jeffrey S. Ross

First Author: Filippo Pietrantonio